Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical Samples

Immunological Reviews

Volumn 127, Issue 1, 1992, Pages 5-24

  Abrams, John S ^a,b,c   Roncarolo, Maria‐Grazia ^a,b,c   Yssel, Hans ^a,b,c   Andersson, Ulf ^a,b,c   Gleich, Gerald J ^a,b,c   Silver, Jon E ^a,b,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 5; MONOCLONAL ANTIBODY; CYTOKINE;

ANIMAL; BIOSYNTHESIS; CELL CULTURE; EOSINOPHILIA; HELMINTHIASIS; HUMAN; IMMUNOASSAY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY; MONOCYTE; MOUSE; PERITONEUM TUMOR; RAT; REVIEW; SUPPRESSOR CELL; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLERGY; ANGIONEUROTIC EDEMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; MALE; MYALGIA; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; EOSINOPHILIA; HELMINTHIASIS; HUMAN; IMMUNOASSAY; INTERLEUKIN-10; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; MONOCYTES; PERITONEAL NEOPLASMS; RATS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR;

EID: 0026611676     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1992.tb01406.x     Document Type: Article

References (75)

1. Development of rat anti‐mouse interleukin 3 monoclonal antibodies which neutralize bioactivity in vitro
2. Serum interleukin‐6 levels correlate with disease status in patients with epithelial ovarian cancer
3. Macrophage deactivation by interleukin 10
4. Elevated serum levels of interleukin‐5 in patients with the syndrome of episodic angioedema and eosinophilia
5. Molecular cloning and expression of the gene encoding human eosinophil differentiation
6. General principle of immunoassay
7. Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin‐4
8. Antibody to interleukin‐5 inhibits helminth‐induced eosinophilia in mice
9. The role of helper T cell products in mouse B cell differentiation and isotype regulation
10. IL‐10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL‐10 produced by monocytes
11. IL‐10 and viral IL‐10 strongly reduce antigen‐specific human T cell proliferation by diminishing the antigen‐presenting capacity of monocytes via downregulation of class II MHC expression
12. IL‐10 and viral IL‐10 (v‐IL‐10) inhibit IL‐4 induced IgE synthesis in the induction phase
13. Interleukin‐5 is a human basophilopoiet‐in: Induction of histamine content and basophilic differentiation of HL‐60 cells and of peripheral blood basophil‐eosinophil progenitors
14. Interleukin 5 messenger RNA expression by eosinophils in the intestinal muscosa of patients with coeliac disease
15. Cytokines as mediators of chronic inflammatory disease
16. T cells from eosinophilic patients produce inlerleukin‐5 with interleukin‐2 stimulation
17. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
18. IL‐10 inhibits cytokine production by activated macrophages
19. IL‐10 acts on the antigen‐presenting cells to inhibit cytokine production by Thl cells
20. Sputum cell counts in airway disease: a useful sampling technique
21. Episodic angioedema associated with eosinophilia
22. Interleukin 10 (IL‐10), a novel B cell stimulatory factor: unresponsiveness of X chromosome‐linked immunodeficiency B cells
23. Mycobacterium leprae specific T cells from a tuberculoid leprosy patient suppress HLA‐DR3 restricted T cell responses to an immunodominant epitope on 65kDa hsp of mycobacteria
24. Association of the eosinophilia‐myalgia syndrome with the ingestion of tryptophan
25. Differential effects of interleukin‐4 and ‐10 on interleukin‐2‐induced interferon‐γ synthesis and lymphokine‐activated killer activity
26. Heterogeneous enzyme immunoassay
27. Structure of the mouse interleukin‐10 gene and chromosomal localization of the mouse and human genes
28. GM‐CSF and interleukin‐3 released by human peripheral blood eosinophils and neutrophils
29. Yersinia Enterocolitica activates a helper type 1 ‐like T cell subset in reactive arthritis
30. The expression and characterization of recombinant mouse IL‐3
31. Interleukin‐5 and the post‐treatment eosinophilia in patients with onchocerciasis
32. Regulation of parasite‐induced eosinophilia: Selectively increased interIeukin‐5 production in helminth‐infected patients
33. Recombinant human interleukin 5 is a selective activator of human eosinophil function
34. Interleukin‐2 treatment associated eosinophilia is mediated by interleukin‐5 production
35. IL‐10: a novel cytokine growth cofactor for mature and immature T cells
36. Activation of the interleukin‐3 gene by chromosome translocation in acute lymphocyte leukemia with eosinophilia
37. Expression of murine and human granulocyte‐macrophage colony‐stimulating factors in S. cerevisiae: mutagenesis of the potential glycosylation sites
38. Homology of cytokine synthesis inhibitory factor (IL‐10) to the Epstein‐ Barr virus gene BCRFI
39. Expression of mRNA and immunoreactivity for the granulocyte/ macrophage‐colony stimulating factor (GM‐CSF) in activated human eosinophils
40. Specific assays for cytokine production by T cells
41. Mouse interleukin‐3: Recombinant cDNA cloning, expression, and characterization
42. A review ‐ “B‐cell factors” are pleiotropic
43. Isolation and characterization of an expressible cDNA encoding human IL‐3. Induction of IL‐3 mRNA in human T cell clones
44. Interleukin 5 and the phenol‐typically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome
45. Hypodense eosinophils and interleukin 5 activity in the blood of a patient with the eosinophilia‐myalgia syndrome
46. Mast cell lines produce lymphokines in response to cross‐linkage of FcERi or to calcium ionophores
47. IL‐10 is a potent growth and differentiation factor for activated human B lymphocytes
48. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T‐cell clones
49. Detection of Interleukin‐5 messenger RNA in Reed‐Sternberg cells of Hodgkin's disease with eosinophilia
50. Assessment of cytokines by immunofluorescenee and the paraformaldehyde‐saponin procedure
51. Immediate and late allergic airway response of allergic rhinitis patients to segmental antigen challenge: Characterization of eosinophil and mast cell mediators
52. Interleukin‐10: a novel stimulatory factor for mast cells and their progenitors
53. Administration of interleukin‐2 (IL‐2) results in increased plasms concentrations of IL‐5 and eosinophilia in patients with cancer
54. A simple method for ranking the affinities of monoclonal antibodies
55. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein‐Barr virus open reading frame BCRFI
56. Cytokines in disease
57. Role of IL‐5 in iL‐2 induced eosinophilia. In vivo and in vitro expression of IL‐5 mRNA by IL‐2
58. Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells
59. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA‐enhancing factor and eosinophil colony‐stimulating factor activities: Relationship to interleukin 5
60. T cell activation inducing epitopes of the house dust mite allergen Der p I. Induction of a restricted cytokine production profile of Der p I‐specific T cell clones upon antigen‐specific activation
61. Analysis of T lymphocytes cloned from the synovial fluid and blood of a patient with Lyme arthritis